Author

Adel Samson

University of LeedsORCID 0000-0002-3081-7850Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Amy Moran· 2 shared Karen J. ScottiD· 2 shared Russell Hughes· 2 shared Stephen D. C. GriffiniD· 2 shared Adam C. ConnoriD· 1 shared Alan A. MelcheriD· 1 shared Alyn L. CratchleyiD· 1 shared Andrew MacdonaldiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Amy Moran

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancersPeer-reviewedSep 22, 2026

The immune and genetic heterogeneity of Hepatocellular Carcinoma, with a focus on multifocal disease

Adam C. Connor, Leon Chang, Emma J. West…·Adel Samson

This study examines genetic and immune heterogeneity in HCC, finding significant discordance in genetic and immune profiles between multifocal tumours.

DOI 10.3390/cancers18193079

humanwhole-exome sequencing

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 18, 2025

Oncolytic Reovirus mediates innate-driven SARS-CoV-2 elimination in the absence of cell toxicity

Samantha Yolotzin García Cárdenas, Gemma Swinscoe, Amy Moran…·Stephen D. C. Griffin

This paper shows that oncolytic Reovirus can eliminate SARS-CoV-2 in lung cells without causing toxicity by enhancing innate antiviral responses.

DOI 10.64898/2025.12.17.694833

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 23, 2024

IFNB induced by non-lytic virus immunotherapy promotes improved survival in hepatocellular carcinoma, mediated by MHCII-independent cytotoxic CD4+ T-cells

Russell Hughes, Amy Moran, Karen J. Scott…·Stephen D. C. Griffin

This paper shows that uv-inactivated reovirus combined with sorafenib improves survival in HCC by promoting IFNβ-induced cytotoxic CD4+ T-cell responses that are MHCII-independent.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky